BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 23158016)

  • 1. Clinical outcome in IL-10- and IL-10 receptor-deficient patients with or without hematopoietic stem cell transplantation.
    Engelhardt KR; Shah N; Faizura-Yeop I; Kocacik Uygun DF; Frede N; Muise AM; Shteyer E; Filiz S; Chee R; Elawad M; Hartmann B; Arkwright PD; Dvorak C; Klein C; Puck JM; Grimbacher B; Glocker EO
    J Allergy Clin Immunol; 2013 Mar; 131(3):825-30. PubMed ID: 23158016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy.
    Kotlarz D; Beier R; Murugan D; Diestelhorst J; Jensen O; Boztug K; Pfeifer D; Kreipe H; Pfister ED; Baumann U; Puchalka J; Bohne J; Egritas O; Dalgic B; Kolho KL; Sauerbrey A; Buderus S; Güngör T; Enninger A; Koda YK; Guariso G; Weiss B; Corbacioglu S; Socha P; Uslu N; Metin A; Wahbeh GT; Husain K; Ramadan D; Al-Herz W; Grimbacher B; Sauer M; Sykora KW; Koletzko S; Klein C
    Gastroenterology; 2012 Aug; 143(2):347-55. PubMed ID: 22549091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unrelated donor hematopoietic stem cell transplantation for infantile enteropathy due to IL-10/IL-10 receptor defect.
    Gassas A; Courtney S; Armstrong C; Kapllani E; Muise AM; Schechter T
    Pediatr Transplant; 2015 Jun; 19(4):E101-3. PubMed ID: 25761563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic Characterization of Very Early-Onset Inflammatory Bowel Disease with Interleukin-10 Signaling Deficiency: Based on a Large Cohort Study.
    Zheng C; Huang Y; Hu W; Shi J; Ye Z; Qian X; Huang Z; Xue A; Wang Y; Lu J; Tang Z; Wu J; Wang L; Peng K; Zhou Y; Miao S; Sun H
    Inflamm Bowel Dis; 2019 Mar; 25(4):756-766. PubMed ID: 30212871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with early relapse of primary hemophagocytic syndromes or with persistent CNS involvement may benefit from immediate hematopoietic stem cell transplantation.
    Sparber-Sauer M; Hönig M; Schulz AS; zur Stadt U; Schütz C; Debatin KM; Friedrich W
    Bone Marrow Transplant; 2009 Sep; 44(6):333-8. PubMed ID: 19252534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful hematopoietic stem cell transplantation from an unrelated donor in a child with interferon gamma receptor deficiency.
    Moilanen P; Korppi M; Hovi L; Chapgier A; Feinberg J; Kong XF; Boisson-Dupuis S; Arola M; Casanova JL; Saarinen-Pihkala UM
    Pediatr Infect Dis J; 2009 Jul; 28(7):658-60. PubMed ID: 19451859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [T-cell-depleted HLA non-identical bone marrow transplantation in the child: prevention of graft-versus-host reaction by administration of donor T lymphocytes alloreactive against the recipient].
    Cavazzana-Calvo M; André-Schmutz I; Hacein-Bey S; Schindler J; Vitetta H; Dupuis S; Quartier P; Chedeville G; Vilmer E; Casanova JL; Buffet R; Caillat-Zucman S; Radford I; Le Deist F; Fischer A
    J Soc Biol; 2001; 195(1):65-8. PubMed ID: 11530503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-10 and interleukin-10-receptor defects in inflammatory bowel disease.
    Shah N; Kammermeier J; Elawad M; Glocker EO
    Curr Allergy Asthma Rep; 2012 Oct; 12(5):373-9. PubMed ID: 22890722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-10 and IL-10 receptor defects in humans.
    Glocker EO; Kotlarz D; Klein C; Shah N; Grimbacher B
    Ann N Y Acad Sci; 2011 Dec; 1246():102-7. PubMed ID: 22236434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining combined immunodeficiency.
    Roifman CM; Somech R; Kavadas F; Pires L; Nahum A; Dalal I; Grunebaum E
    J Allergy Clin Immunol; 2012 Jul; 130(1):177-83. PubMed ID: 22664165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single-center study of hematopoietic stem cell transplantation for primary immune deficiencies (PIDD).
    Dinardo L; Brown V; Perez E; Bunin N; Sullivan KE
    Pediatr Transplant; 2012 Feb; 16(1):63-72. PubMed ID: 22093026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges in the use of allogeneic hematopoietic SCT for ectodermal dysplasia with immune deficiency.
    Fish JD; Duerst RE; Gelfand EW; Orange JS; Bunin N
    Bone Marrow Transplant; 2009 Feb; 43(3):217-21. PubMed ID: 18794870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of idiopathic colitis related to XIAP deficiency with allo-HSCT using reduced-intensity conditioning.
    Tsuma Y; Imamura T; Ichise E; Sakamoto K; Ouchi K; Osone S; Ishida H; Wada T; Hosoi H
    Pediatr Transplant; 2015 Feb; 19(1):E25-8. PubMed ID: 25412586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and virological characteristics of 15 patients with chronic active Epstein-Barr virus infection treated with hematopoietic stem cell transplantation.
    Gotoh K; Ito Y; Shibata-Watanabe Y; Kawada J; Takahashi Y; Yagasaki H; Kojima S; Nishiyama Y; Kimura H
    Clin Infect Dis; 2008 May; 46(10):1525-34. PubMed ID: 18419486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful outcome with second hematopoietic stem cell transplantation in a patient with IL-10R deficiency.
    Kuşkonmaz B; Ayvaz D; Aydemir Y; Erman B; Tavil B; Özen H; Tezcan I; Çetinkaya DU
    Bone Marrow Transplant; 2016 Apr; 51(4):615-6. PubMed ID: 26691419
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
    Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A
    Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-10 in humans: lessons from the gut, IL-10/IL-10 receptor deficiencies, and IL-10 polymorphisms.
    Engelhardt KR; Grimbacher B
    Curr Top Microbiol Immunol; 2014; 380():1-18. PubMed ID: 25004811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic transplantation successfully corrects immune defects, but not susceptibility to colitis, in a patient with nuclear factor-kappaB essential modulator deficiency.
    Pai SY; Levy O; Jabara HH; Glickman JN; Stoler-Barak L; Sachs J; Nurko S; Orange JS; Geha RS
    J Allergy Clin Immunol; 2008 Dec; 122(6):1113-1118.e1. PubMed ID: 18851875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic stem cell transplantation for hemophagocytic lymphohistiocytosis: a retrospective analysis of data from the Italian Association of Pediatric Hematology Oncology (AIEOP).
    Cesaro S; Locatelli F; Lanino E; Porta F; Di Maio L; Messina C; Prete A; Ripaldi M; Maximova N; Giorgiani G; Rondelli R; Aricò M; Fagioli F
    Haematologica; 2008 Nov; 93(11):1694-701. PubMed ID: 18768529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency.
    Al-Mousa H; Al-Shammari Z; Al-Ghonaium A; Al-Dhekri H; Al-Muhsen S; Al-Saud B; Arnaout R; Al-Seraihy A; Al-Jefri A; Al-Ahmari A; Ayas M; El-Solh H
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):818-23. PubMed ID: 20079864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.